Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter H Jones

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
The American Journal of Cardiology|October 2, 2013
The editor's roundtable: hypertriglyceridemiaVincent E Friedewald, Christie M Ballantyne, Harold E Bays, et al.
Journal of Clinical Lipidology|October 16, 2018
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponseAnum Saeed, Salim S Virani, Peter H Jones, et al.
Current Opinion in Lipidology|May 29, 2004
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'Ashok Balasubramanyam, Rajagopal V Sekhar, Farook Jahoor, et al.
Journal of Clinical Lipidology|August 16, 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)Ali M Agha, Peter H Jones, Christie M Ballantyne, et al.
Journal of Clinical Lipidology|May 17, 2017
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experienceAnum Saeed, Salim S Virani, Peter H Jones, et al.
Journal of Lipid Research|January 13, 2012
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemiaAriel Brautbar, Salim S Virani, John Belmont, et al.
Journal of Clinical Lipidology|February 20, 2016
National Lipid Association Annual Summary of Clinical Lipidology 2016Harold E Bays, Peter H Jones, Carl E Orringer, et al.
Current Atherosclerosis Reports|June 20, 2018
Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
Current Atherosclerosis Reports|May 22, 2018
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
The American Journal of Cardiology|January 2, 2007
The editor's roundtable: concurrent hypertension and dyslipidemiaVincent E Friedewald, Peter H Jones, Norman M Kaplan, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
The American Journal of Cardiology|October 2, 2013
The editor's roundtable: hypertriglyceridemiaVincent E Friedewald, Christie M Ballantyne, Harold E Bays, et al.
Journal of Clinical Lipidology|October 16, 2018
Case reports of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition nonresponseAnum Saeed, Salim S Virani, Peter H Jones, et al.
Current Opinion in Lipidology|May 29, 2004
Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'Ashok Balasubramanyam, Rajagopal V Sekhar, Farook Jahoor, et al.
Journal of Clinical Lipidology|August 16, 2021
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH)Ali M Agha, Peter H Jones, Christie M Ballantyne, et al.
Journal of Clinical Lipidology|May 17, 2017
A simplified pathway to proprotein convertase subtilisin/kexin type 9 inhibitor prior authorization approval: A lipid clinic experienceAnum Saeed, Salim S Virani, Peter H Jones, et al.
Journal of Lipid Research|January 13, 2012
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemiaAriel Brautbar, Salim S Virani, John Belmont, et al.
Journal of Clinical Lipidology|February 20, 2016
National Lipid Association Annual Summary of Clinical Lipidology 2016Harold E Bays, Peter H Jones, Carl E Orringer, et al.
Current Atherosclerosis Reports|June 20, 2018
Correction to: Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
Current Atherosclerosis Reports|May 22, 2018
Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future DirectionsAnum Saeed, Kaustubh Dabhadkar, Salim S Virani, et al.
The American Journal of Cardiology|January 2, 2007
The editor's roundtable: concurrent hypertension and dyslipidemiaVincent E Friedewald, Peter H Jones, Norman M Kaplan, et al.
Pageof 11